1. Kennedy DG, O’Mahony AM, Culligan EP, O’Driscoll CM, Ryan KB. Strategies to Mitigate and Treat Orthopaedic Device-Associated Infections. Antibiotics (Basel). 2022; 15;11(12):1822.
2. Trampuz A, Widmer AF. Infections Associated with Orthopedic Implants. Curr Opin Infect Dis 2006; 19: 349–356.
3. Gatti M, Barnini S, Guarracino F, Parisio EM, Spinicci M, Viaggi B, D’Arienzo S, Forni S, Galano A, Gemmi F. Orthopaedic Implant-Associated Staphylococcal Infections: A Critical Reapp-
raisal of Unmet Clinical Needs Associated with the Implementation of the Best Antibiotic Choice. Antibiotics 2022; 11: 406.
4. McNally M, Sousa R, Wouthuyzen-Bakker M, et al. The EBJIS definition of periprosthetic joint infection. Bone Joint J 2021; 103-B: 18-25.
5. Anderson JM, McNally AK. Biocompatibility of implants:lymphocyte/macrophage interactions. Semin Immunopathol. 2011;3 3:221–233.
6. Antony S, Farran Y. Prosthetic Joint and Orthopedic Device Related Infections. The Role of Biofilm in the Pathogenesis and Treatment. Infectious Disorders – Drug Targets,2016; 16(1), 22–27.
7. Achermann Y, Goldstein EJ, Coenye T, Shirtliff ME. Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev 2014; 419-440.
8. Welliver RC Jr, Hanerhoff BL, Henry GD, Kohler T.S. Significance of Biofilm for the Prosthetic Surgeon. Curr Urol Rep 2014; 15(6): 1-7.
9. Arciola, C.R.; Campoccia, D.; Speziale, P.; Montanaro,L.; Costerton, J.W. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for
biofilm-resistant materials. Biomaterials 2012; 22(26):5967-5982.
10. Frei E, Hodgkiss-Harlow K, Rossi PJ, Edmiston CE Jr, Bandyk DF. Microbial Pathogenesis ofBacterial Biofilms A Causative Factor of VascularSurgical Site Infection Vasc Endovascular Surg
2011; 45(8): 688-696.
11. Jacqueline C, Caillon J. Impact of Bacterial Biofilm on the Treatment of Prosthetic Joint Infections. J. Antimicrob. Chemother 2014;69 (Suppl. S1): i37–i40.
12. Neut D, van der Mei HC, Bulstra SK, Busscher HJ. The Role of Small-Colony Variants in Failure to Diagnose and Treat Biofilm Infections in Orthopedics. Acta Orthop 2007; 78: 299–308.
13. Zimmerli W, Zak O, Vosbeck K. Experimental hematogenous infection of subcutaneously implanted foreign bodies. Scand J Infect Dis. 1985; 17:303–310.
14. Lewis SS, Dicks KV, Chen LF, Bolognesi MP, Anderson DJ, Sexton DJ, Moehring RW. Delay in diagnosis of invasive surgical site infections following knee arthroplasty versus hip arthroplasty.
Clin Infect Dis 2015;60(7):990-996
15. Alt V, Rupp M, Langer M, Baumann F, Trampuz A. Can the oncology classification system be used for prosthetic joint infection? The PJI-TNM system. 2020; 9(2):79-81.
16. Patel R. Periprosthetic Joint Infection. N Engl J Med. 2023;388(3):251-262.
17. Bülow E, Hahn U, Andersen IT, Rolfson O, Pedersen AB, Hailer NP. Prediction of early periprosthetic joint infection after total hip arthroplasty. Clin Epidemiol 2022; 14: 239-53.
18. Wang Q, Goswami K, Shohat N, Aalirezaie A, Manrique J, Parvizi J. Longer operative time results in a higher rate of subsequent periprosthetic joint infection in patients undergoing primary
joint arthroplasty. J Arthroplasty 2019; 34: 947-53.
19. Peel, T.N.; Cheng, A.C.; Buising, K.L.; Choong, P.F.M. Microbiological Aetiology, Epidemiology, and Clinical Profile of Prosthetic Joint Infections: Are Current Antibiotic Prophylaxis Guide-
lines Effective? Antimicrob. Agents Chemother 2012; 56, 2386–2391.
20. Tai DBG, Patel R, Abdel MP, BerbariEF, Tande AJ. Microbiology of hip and knee periprosthetic joint infections: a database study. Clin Microbiol Infect 2022; 28:255-259.
21. Marigi EM, Bartels DW, Yoon JH,Sperling JW, Sanchez-Sotelo J. Antibiotic prophylaxis with cefazolin is associated with lower shoulder periprosthetic joint infection rates than non-cefazolin
alternatives. J Bone Joint Surg Am 2022; 104:872-80.
22. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR. Diagnosis and management of prosthetic joint infection: clinical practice guidelines
by the Infectious Diseases Society of America. Clin Infect Dis 2013;56(1):e1–e25
23. Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev 2014;27(2):302-345.
24. Barrett L, Atkins B. The clinical presentation of prosthetic joint infection. J Antimicrob Chemother. 2014;69 Suppl 1:i25-7.
25. Parvizi J, Tan TL, Goswami K, Higuera C, Della Valle C, Chen AF, Shohat N. The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. J Arthrop-
lasty 2018;33:1309–1314.
26. Kim HS, Park JW, Moon SY, Lee YK, Ha YC, Koo KH. Current and future burden of periprosthetic joint infection from national claim database. J Korean Med Sci 2020;35:e410.
27. Azad MA, Patel R. Practical Guidance for Clinical Microbiology Laboratories: Microbiologic diagnosis of implant-associated infections. Clin Microbiol Rev. 2024;20:e0010423.
28. Sigmund, I.K.; Puchner, S.E.;Windhager, R. Serum Inflammatory Biomarkers in the Diagnosis of Periprosthetic Joint Infections.Biomedicines 2021; 9: 1128.
29. Sax FH, Hoyka M, Blersch BP, Fink B. Diagnostics in Late Periprosthetic Infections—Challenges and Solutions. Antibiotics 2024; 13, 351.
30. Rockov ZA, Clarke HD, Grys TE,Chang Y-HH, Schwartz AJ. Is there an optimal cutoff for aspiration fluid volüme in the diagnosis of periprosthetic joint infection? J Arthroplasty 2020; 35:
2217-22.
31. Kuiper JWP, Verberne SJ, Vos SJ, van Egmond PW. Does the Alpha Defensin ELISA Test Perform Better than the Alpha Defensin Lateral Flow Test for PJI Diagnosis? A Systematic Review and
Meta-Analysis of Prospective Studies Clin Orthop Relat Res. 2020; 478: 1333–1344.
32. McNabb DC, Dennis DA, Kim RH, Miner TM, Yang CC, Jennings JM. Determining False Positive Rates of Leukocyte Esterase Reagent Strip When Used as a Detection Tool for Joint Infection.
J. Arthroplast. 2017; 32: 220–222.
33. Grünwald L, Schmidutz F, Döttger P, Erne F, Schreiner AJ, Hemmann P. Leukocyte Esterase and Alpha-Defensin in Periprosthetic Joint Infection: Predictive Quality and Correlation in a
Prospective Study. Int. Orthop. 2023; 47: 2663–2668.
34. Tsaras G, Maduka-Ezeh A, Inwards CY, Mabry T, Erwin PJ, Murad MH, Montori VM, West CP, Osmon DR, Berbari EF. Utility of intraoperative frozen section histopathology in the diagnosis
of periprosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am 2012;94:1700–1711.
35. Peel TN, Spelman T, Dylla BL, Hughes JG, Greenwood-Quaintance KE, Cheng AC, Mandrekar JN, Patel R.. Optimal periprosthetic tissue specimen number for diagnosis of prosthetic joint
infection. J Clin Microbiol 2017;55:234–243.
36. Al-Mayahi M, Cian A, Lipsky BA, Suvà D, Müller C, Landelle C, Miozzari HH, Uçkay I. Administration of antibiotic agents before intraoperative sampling in orthopedic infections alters
culture results. J Infect 2015;71:518–525.
37. Krenn, V.; Morawietz, L.; Jakobs, M.; Kienapfel, H.; Ascherl, R.; Bause, L.; Kuhn, H.; Matziolis, G.; Skutek, M.; Gehrke, T. Joint endoprosthesis pathology. Histopathological diagnostics and
classification. Pathologe 2011; 32: 210–219.
38. Trampuz A, Piper KE, Jacobson MJ,et al. Sonication of removed hip and kneeprostheses for diagnosis of infection. N Engl J Med 2007; 357: 654-63.
39. Oliva A, Miele MC, Al Ismail D, Di Timoteo F, De Angelis M, Rosa L, Cutone A, Venditti M, Mascellino MT, Valenti P, et al. Challenges in the Microbiological Diagnosis of Implant-Associated
Infections: A Summary of the CurrentKnowledge. Front Microbiol. 2021; 12: 750460.
40. Watanabe S, Kamono E, Choe H, Ike H, Inaba Y, Kobayashi N. Differences in Diagnostic Sensitivity of Cultures Between Sample Types in Periprosthetic Joint Infections: A Systematic Review
and Meta-Analysis. J Arthroplasty. 2024;13:S0883-5403(24)00232-8.
41. Sigmund, I.K.; Windhager, R.; Sevelda, F.; Staats, K.; Puchner, S.E.; Stenicka, S.; Thalhammer, F.; Holinka, J. Multiplex PCR Unyvero I60 ITI Application Improves Detection of Low-Virulent
Microorganisms in Periprosthetic Joint Infections. Int. Orthop 2019; 43: 1891–1898.
42. Su S, Wang R, Zhou R, Bai J, Chen Z, Zhou F. Higher diagnostic value of next-generation sequencing versus culture in periprosthetic joint infection: A systematic review and meta-analysis.
Knee Surg Sports Traumatol Arthrosc. 2024 May 7. doi: 10.1002/ksa.12227. Epub ahead of print.
43. Zajonz, D.; Wuthe, L.; Tiepolt, S.; Brandmeier, P.; Prietzel, T.; von Salis-Soglio, G.F.; Roth, A.; Josten, C.; Heyde, C.-E.; Ghanem, M.Diagnostic Work-up Strategy for Periprosthetic Joint Infe-
ctions after Total Hip and Knee Arthroplasty: A 12-Year Experience on320 Consecutive Cases. Patient Saf Surg 2015; 9: 20.
44. Sconfienza LM, Signore A, Cassar-Pullicino V, Cataldo MA, Gheysens O, Borens O, Trampuz A, Wörtler K, Petrosillo N, Winkler H, Vanhoenacker FMHM, Jutte PC, Glaudemans AWJM. Di-
agnosis of peripheral bone and prosthetic joint infections: overview on the consensus documents by the EANM, EBJIS, and ESR (with ESCMID endorsement). Eur Radiol. 2019;29(12):6425-
6438.
45. Romanò CL, Petrosillo N, Argento G, Sconfienza LM, Treglia G,Alavi A, et al. The role of imaging techniques to define a periprosthetichip and knee joint infection: multidisciplinary consen-
susstatements. J Clin Med 2020;9:2548.
46. Signore A, Jamar F, Israel O, Buscombe J, Martin-Comin J, LazzeriE. Clinical indications, image acquisition and data interpretation forwhite blood cells and anti-granulocyte monoclonal
antibody scintigraphy:an EANM procedural guideline. Eur J Nucl Med MolImaging. 2018;45:1816–1831.
47. Kiran M, Donnelly TD, Armstrong C, Kapoor B, Kumar G, PeterV. Diagnostic utility of fluorodeoxyglucose positron emission tomography in prosthetic joint infection based onMSIS criteria.
Bone Joint J. 2019;101-B:910–4.
48. Argenson JN, Arndt M, Babis G, et al. Hip and knee section, treatment, debridement and retention of implant: proceedings of international consensus on orthopedic infections. J Arthroplasty.
2019;34(2S):S399–419.
49. Sendi P, Zimmerli W. Antimicrobial treatment concepts for orthopaedicdevice-related infection. Clin Microbiol Infect. 2012;18(12):1176–84.
50. Bernard L, Arvieux C, Brunschweiler B, et al. Antibiotic therapy for 6 or 12 weeks for prosthetic joint infection. N Engl J Med. 2021;384(21):1991–2001.
51. Löwik CAM, Parvizi J, Jutte PC, Zijlstra WP, Knobben BAS, Xu C, Goswami K, Belden KA, Sousa R, Carvalho A, Martínez-Pastor JC, Soriano A, Wouthuyzen-Bakker M. Debridement, Antibi-
otics, and Implant Retention Is a Viable Treatment Option for Early Periprosthetic Joint Infection Presenting More Than 4 Weeks After Index Arthroplasty. Clin Infect Dis. 2020;27;71(3):630-
636.
52. Biring GS, Kostamo T, Garbuz DS, Masri BA, Duncan CP. Two-stage revision arthroplasty of the hip for infection using an interim articulated Prostalac hip spacer: a 10- to 15-year follow-up
study. J Bone Joint Surg Br 2009;91(11):1431-7.
53. Lora-Tamayo J, Mancheño-Losa M, Meléndez-Carmona MÁ, Hernández-Jiménez P, Benito N, Murillo O. Appropriate Duration of Antimicrobial Treatment for Prosthetic Joint Infections: A
Narrative Review. Antibiotics (Basel). 2024; 23:13(4):293.
54. Li C, Renz N, Trampuz A. Management of Periprosthetic Joint Infection. Hip Pelvis. 2018;30(3):138-146
55. Le Vavasseur B, Zeller V.Antibiotic Therapy for Prosthetic Joint Infections: An Overview. Antibiotics 2022, 11, 486.
56. Jia Y, Chen J, Liang W, Xiong Y, Peng Z, Wang G. Differences in Efficacy between Short-and Long-Course Antibiotic Agentsfor Joint Prosthesis Infection: A Systematic Review and Meta-A-
nalysis. Surg. Infect. 2022;23: 616–624.
57. Olearo F, Zanichelli V, Exarchakou A, Both A, Uςkay I, Aepfelbacher M, Rohde H. The Impact of Antimicrobial TherapyDuration in the Treatment of Prosthetic Joint Infections Depending
on Surgical Strategies: A Systematic Review and Meta-analysis. Open Forum Infect Dis 2023;10: ofad246.
58. Yen HT, Hsieh RW, Huang CY, Hsu TC, Yeh T, Chen YC, Chen W-S, Lee C-C Short-course versus long-courseantibiotics in prosthetic joint infections: A systematic review and meta-analysis
of one randomized controlled trial plus nineobservational studies. J. Antimicrob. Chemother. 2019; 74: 2507–2516.
59. Olesen UK, Pedersen NJ, Eckardt H, Lykke-Meyer L, Bonde CT, Singh UM, et al.The cost of infection in severe open tibial fractures treated with a free flap. Int Orthop 2017;41:1049e55.
60. Bezstarosti H, Van Lieshout EMM, Voskamp LW, Kortram K, Obremskey W,McNally MA, et al. Insights into treatment and outcome of fracture-relatedinfection: a systematic literature review.
Arch Orthop Trauma Surg 2019;139:61e72.
61. Young S, Lie SA, Hallan G, Zirkle LG, Engesæter LB, Havelin LI. Risk factors for infection after 46,113 intramedullary nail operations in low- and middle-income countries. World J Surg
2013;37:349–355.
62. Metsemakers WJ, Morgenstern M, McNally MA, Moriarty TF, McFadyen I,Scarborough M, et al. Fracture-related infection: a consensus on definition from an international expert group.
Injury 2018;49:505e10
63. Govaert GAM, Kuehl R, Atkins BL, Trampuz A, Morgenstern M, Obremskey WT, Verhofstad MHJ, McNally MA, Metsemakers WJ; Fracture-Related Infection (FRI) Consensus Group.
Diagnosing Fracture-Related Infection: Current Concepts and Recommendations. J Orthop Trauma. 2020;34(1):8-17.
64. Kuehl R, Tschudin-Sutter S, Morgenstern M, Dangel M, Egli A, Nowakowski A,et al. Time-dependent differences in management and microbiology of orthopaedicinternal fixation-associated
infections: an observational prospectivestudy with 229 patients. Clin Microbiol Infect 2019;25:76e81.
65. Ma X, Han S, Ma J, Chen X, Bai W, Yan W, et al. Epidemiology, microbiologyand therapeutic consequences of chronic osteomyelitis in northern China: aretrospective analysis of 255 Patients.
Sci Rep 2018;8:14895.
66. Metsemakers WJ, Kuehl R, Moriarty TF, Richards RG, Verhofstad MHJ,Borens O, et al. Infection after fracture fixation: current surgical and microbiological concepts. Injury 2018;49:511e22.
67. Depypere M, Kuehl R, Metsemakers WJ, Senneville E, McNally MA, Obremskey WT, Zimmerli W, Atkins BL, Trampuz A; Fracture-Related Infection (FRI) Consensus Group. Recommenda-
tions for Systemic Antimicrobial Therapy in Fracture-Related Infection: A Consensus From an International Expert Group. J Orthop Trauma. 2020;34(1):30-41.